关于淋巴管状菌病的OMIC研究:现状和挑战
Xinhe Zhang1,2, Song Liu3, Luning Yang1
1Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Complex, Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Expert review of respiratory medicine
|September 11, 2024
概括
最近的OMICS研究揭示了淋巴管状肌肉病 (LAM) 的潜在新生物标志物,这是一个罕见的肺部疾病,影响女性. 预计将各种omics方法结合起来进行进一步的研究,以提高生物标志物发现和对LAM病原体的理解.
科学领域:
- 生物化学 生化学
- 遗传学 是一个遗传学.
- 肺部病理学 肺部病理学
背景情况:
- 淋巴结核病 (Lymphangioleiomyomatosis,简称LAM) 是一种罕见的,渐进的肺部疾病,主要影响生育年龄的妇女.
- 与健康个体相比,在LAM患者中观察到分子的差异表达,包括血管内皮生长因子D (VEGF-D),这表明潜在的生物标志物作用.
研究的目的:
- 审查最近的奥米克研究 (基因组学,转录组学,蛋白质组学,代谢组学) 的进展,以发现淋巴结核病 (LAM) 生物标志物.
- 获取和总结过去十年通过omics技术识别的LAM生物标志物的文献.
主要方法:
- 使用PubMed和其他检索工具进行文献搜索.
- 在过去10年中发表的与LAM生物标志物发现相关的omics研究的系统综述.
主要成果:
- 识别了各种分子,这些分子有可能成为LAM的新生物标志物.
- 来自LAM的基因组学,转录组学,蛋白质组学和代谢组学研究结果的摘要.
结论:
- 需要对更大的样本大小进行进一步的研究,以验证潜在的LAM生物标志物并阐明疾病机制.
- 结合多种omics方法有望发现新的生物标志物并推进对LAM病原学的理解.
相关概念视频
Probiotics
Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Introduction to the Human Microbiota
Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity, and disease...
The Oral Microbiota
The oral microbiome includes a complex ecosystem comprising over 700 microbial species, identified through genomic sequencing and culture-based analyses to date. This community includes a core microbiome, found universally among individuals, and a variable component influenced by environmental factors such as diet, lifestyle, and host genetics. Site-specific conditions, including oxygen gradients, pH levels, and nutrient availability, determine the spatial distribution of these microorganisms...
Microbiota of the Stomach and Small Intestine
The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...
Dysbiosis of the Gut Microbiota
The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...


